11/13/2018 2:59 PM
Leerink resumed coverage on Adamas Pharmaceuticals Inc (NASDAQ:ADMS) with an "outperform" rating and $20 price target -- a nearly 75% premium to last night's close. After surging as much as 6.9% in e...
8/3/2018 2:52 PM
Stocks are mostly higher today, with the Dow rallying on a strong move from IBM stock. Among other stocks making notable pushes higher are drug names Adamas Pharmaceuticals Inc (NASDAQ:ADMS) and La...
10/30/2017 9:59 AM
Analysts are weighing in on pharmaceutical stock Adamas Pharmaceuticals Inc (NASDAQ:ADMS), Chinese e-commerce name Alibaba Group Holding Ltd (NYSE:BABA), and online retail platform Shopify Inc (US)...
8/25/2017 10:14 AM
Analysts are weighing in on drugmaker Adamas Pharmaceuticals Inc (NASDAQ:ADMS), online review concern Yelp Inc (NYSE:YELP), and tech stock VMware, Inc. (NYSE:VMW). Here's a quick roundup of today's ...
12/23/2015 9:29 AM
The Dow looks ready for a third straight win, with oil prices on the mend. Among the equities in focus are athletics retailer Nike Inc (NYSE:NKE), as well as biotechs Adamas Pharmaceuticals Inc (...